Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | LIPE | Q05469 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29185988 | 0.90 | MEN1 (0.44) | MEN1KMT2AKIF11CYP1A2ELANE | |
| SCHEMBL6284986 | 0.87 | KMT2A (0.64) | MEN1KMT2AKIF11ELANECA1 | |
| Toluene SCHEMBL28917433 | 0.85 | LMNA (0.46) | MEN1KMT2ACYP1A2ELANENPC1 | |
| SCHEMBL7063178 | 0.80 | ELANE (0.50) | MEN1KMT2ACYP1A2ELANELIPE | |
| SCHEMBL56865 | 0.80 | KMT2A (0.50) | MEN1KMT2ACYP1A2ELANELIPE | |
| SCHEMBL31366711 | 0.80 | CYP2C9 (0.58) | MEN1KMT2ACYP1A2HPGDNPC1 | |
| Guanidine SCHEMBL7467156 | 0.79 | ELANE (0.46) | MEN1KMT2ACYP1A2ELANELIPE | |
| SCHEMBL59462 | 0.78 | ELANE (0.48) | MEN1KMT2ACYP1A2ELANELIPE | |
| SCHEMBL1850368 | 0.78 | KMT2A (0.54) | MEN1KMT2AKIF11CYP3A4MAPT | |
| SCHEMBL348122 | 0.78 | MEN1 (0.54) | MEN1KMT2AKIF11ELANEHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110940740-B | Detection method of L-alpha-glycerophosphorylcholine isomer | 江苏威奇达药业有限公司 | 2022-09-13 | — | — | CN | claimed |
| CN-113214339-A | Panaxadiol derivatives, preparation method and medical application thereof | 延边大学 | 2021-08-06 | — | — | CN | claimed |
| CN-110940740-A | Detection method of L- α -glycerophosphorylcholine isomer | 上海现代制药海门有限公司 | 2020-03-31 | — | — | CN | claimed |
| CN-110128301-A | A kind of blue-green alge remover and its environment-friendly preparation method thereof | 上海裕兰生物科技有限公司 | 2019-08-16 | — | — | CN | claimed |
| EP-3256508-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | Covestro Deutschland AG (DE) | 2017-12-20 | — | — | EP | claimed |
| CN-106046100-A | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases | 拜耳知识产权有限责任公司 | 2016-10-26 | — | — | CN | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| CN-102105149-A | Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity | BRISTOL MYERS SQUIBB CO | 2011-06-22 | — | — | CN | claimed |
| CN-101166733-A | Pyrazole derivatives as phosphodiesterase 4 inhibitors | MEMORY PHARM CORP (US) | 2008-04-23 | — | — | CN | claimed |
| CN-1890216-A | Carboxylic acid amine derivatives | MERCK PATENTE GES MIT BESCHRON (DE) | 2007-01-03 | — | — | CN | claimed |
| US-6946557-B2 | Process for producing optically active ethyl (3R, 5S, 6E)-7-[2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-09-20 | — | — | US | claimed |
| CN-1204122-C | Process for the isolation of optically active ethyl (3R,5S,6E) -7- [ 2-cyclopropyl-4- (4-fluorophenyl) quinolin-3-yl ] -3, 5-dihydroxy-6-heptenoate | NISSAN CHEMICAL IND LTD (JP) | 2005-06-01 | — | — | CN | claimed |
| US-20050075502-A1 | Process for producing optically active ethly (3r, 5s, 6e)-7- [2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-04-07 | — | — | US | claimed |
| CN-1468223-A | Process for producign optically active ethyl (3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate | 大赛璐化学工业株式会社 | 2004-01-14 | — | — | CN | claimed |
| EP-1334967-A1 | PROCESS FOR PRODUCIGN OPTICALLY ACTIVE ETHYL (3R,5S,6E)-7- 2-CYCLOPROPYL-4-(4-FLUOROPHENYL)QUINOLIN-3-YL]-3,5-DIHYDROXY-6-HEPTENOATE | Daicel Chemical Industries, Ltd. (JP) | 2003-08-13 | — | — | EP | claimed |
| EP-0161989-B1 | COMPOSITIONS FOR THE TREATMENT OF FRUITS AND VEGETABLES BY THERMAL FOGGING AND TREATMENT PROCESS USING THESE COMPOSITIONS | XEDA INTERNATIONAL (FR) | 1988-08-10 | — | — | EP | claimed |
| CN-122031506-A | Chiral control | 波涛生命科学有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-118922409-A | Asymmetric piperazine-based cationic lipids | 翻译生物公司 | 2024-11-08 | — | — | CN | disclosed |
| EP-0401817-A2 | Reagents for rapid peptide synthesis | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1990-12-12 | — | — | EP | disclosed |
| US-3954967-A | Method of producing microcolloidal aqueous emulsions of unsaturated organic insecticidal compounds | VANGUARD CHEMICAL COMPANY, INC. (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075502-A1 | Process for producing optically active ethly (3r, 5s, 6e)-7- [2-cycloproply-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate | CNPY3, CYP8B1, HPD | MEN1 4620/4885KMT2A 4367/4885KIF11 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.